Cleancard

Cleancard is a United States-based company specializing in developing innovative diagnostic solutions. With a small team of three employees, Cleancard has achieved a revenue of $2.5 million. The company focuses on providing at-home diagnostic tests that deliver lab-quality results. Their flagship product is a rapid urine-based screening system capable of detecting prostate, bladder, and ovarian cancers within 30 minutes. Cleancard is committed to expanding its platform technology to identify a wider range of conditions through a single urine sample. Cleancard's unique approach to diagnostics sets it apart by offering convenient, accessible, and timely results. Their technology aims to empower individuals to take control of their health by providing them with rapid and reliable information about their well-being. For more information about Cleancard and its products, visit their website at cleancard.bio.